Immunotherapy is currently a fully established treatment modality in oncology. It is still a relatively new treatment option which has made the most considerable progress in the therapy of malignant melanoma.
Immunotherapy has been widely used in the therapy of both solid and hematological malignancies during the last decade. This review is focused on the most recent innovations in the field of immunotherapy, which have been made during the last five years and are currently available in the Czech Republic.